National Pharmacy Organizations Write Azar Regarding Drug Importation

NASPA, along with the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), wrote U.S. Department of Health and Human Services Secretary Azar this week regarding state prescription drug importation plans.  All three organizations oppose the approval of a state drug importation program that meets a lower standard than that set by the Drug Supply Chain Security Act (DSCSA).

“[W]e believe importation of non-FDA approved drugs or medications provided by questionable sources has the potential to harm patients, increase out-of-pocket costs for patients, and undermine key efforts underway to enhance the safety and quality of health care delivery for all Americans. Therefore, we urge the Secretary to provide a clear and transparent process that allows for public input when HHS reviews state importation plans.”

Read Full Letter

Leave a Reply